Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederroche.com
Investor Update
Get the latest updates from Investor Update directly as they happen.
Follow now 375 followers
Latest posts
Last updated 4 days ago
[Ad hoc announcement pursuant to Art. 53 LR] Roche reports strong sales growth of +6% at constant exchange rates in the first quarter of 2026; -5% in CHF due to the significant appreciation of the Swiss franc
4 days ago
Group sales were +6% at constant exchange rates (CER)1, -5% when reported...
[Ad hoc announcement pursuant to Art. 53 LR] Roche reports strong sales growth of +6% at constant exchange rates in the first quarter of 2026; -5% in CHF due to the significant appreciation of the Swiss franc
4 days ago
Group sales were +6% at constant exchange rates (CER)1, -5% when reported...
Roche’s fenebrutinib significantly reduced relapses versus standard of care to approximately one every 17 years in RMS
5 days ago
Late-breaking Phase III FENhance 1 and 2 study results showed superiority of...
Roche’s ENSPRYNG (satralizumab) reduces risk of relapses by 68% demonstrating potential to become first treatment for MOGAD
6 days ago
Phase III METEOROID study met its primary endpoint in patients with myelin...
FDA accepts application for Roche’s Gazyva/Gazyvaro for the treatment of the most common form of lupus
6 days ago
Filing acceptance based on phase III ALLEGORY data for Gazyva/Gazyvaro showing a...
Foundation Medicine to Strengthen Monitoring Portfolio with SAGA Diagnostics’ Tumor-Informed Molecular Residual Disease (MRD) Platform
11 days ago
Pathlight™, a personalized, tumor-informed molecular residual disease (MRD) platform, will expand Foundation...
Reminder: Invitation to Roche’s First Quarter Sales 2026 Presentation
11 days ago
Roche will publish its Sales Results for the 1st Quarter 2026 prior...
Reminder: Invitation to Roche’s Virtual AAN Investor Event
12 days ago
We are pleased to invite investors and analysts to participate in our...
Reminder: Invitation to Roche’s Diagnostics Day 2026
13 days ago
The Roche Investor Relations team would like to invite you to the...
Roche receives CE mark for new Elecsys NfL blood test to detect neuroinflammation in multiple sclerosis
14 days ago
The Elecsys NfL blood test detects neuroaxonal damage associated with neuroinflammation in...
Roche launches the cobas MPX-E assay, a new 4-in-1 donor screening test to further safeguard the global blood supply
28 days ago
The cobas MPX-E test provides four critical results (for HIV, HCV, HBV...
Invitation to Roche’s Virtual AAN Investor Event
about 1 month ago
We are pleased to invite investors and analysts to participate in our...